Ongoing development of Xanamem, a unique inhibitor of the 11B-HSD1 enzyme that achieves target engagement in the central nervous system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback